• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on "A phase IB/IIA study of ex vivo expanded allogeneic bone-marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn disease.".

作者信息

Cheng Fang

机构信息

Division of Gastroenterology, Zigong First People's Hospital, Zigong, Sichuan Province, China.

出版信息

Surgery. 2024 May;175(5):1463-1464. doi: 10.1016/j.surg.2023.10.038. Epub 2023 Dec 2.

DOI:10.1016/j.surg.2023.10.038
PMID:38044239
Abstract
摘要

相似文献

1
Comment on "A phase IB/IIA study of ex vivo expanded allogeneic bone-marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn disease.".关于“一项关于体外扩增的同种异体骨髓间充质干细胞治疗直肠阴道瘘型克罗恩病的ⅠB/ⅡA期研究”的评论
Surgery. 2024 May;175(5):1463-1464. doi: 10.1016/j.surg.2023.10.038. Epub 2023 Dec 2.
2
Comments on: "A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone-Marrow Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease".关于《一项关于体外扩增的同种异体骨髓间充质干细胞治疗肛周瘘管型克罗恩病的ⅠB/ⅡA期研究》的评论
Dis Colon Rectum. 2024 Mar 1;67(3):e202. doi: 10.1097/DCR.0000000000003176. Epub 2023 Dec 5.
3
A phase IB/IIA study of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn's disease.一项关于异体骨髓源性间充质干细胞体外扩增治疗直肠阴道瘘型克罗恩病的 Ib/IIa 期研究。
Surgery. 2024 Feb;175(2):242-249. doi: 10.1016/j.surg.2023.07.020. Epub 2023 Sep 1.
4
A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease.一项关于体外扩增的同种异体骨髓间充质干细胞治疗肛周瘘管型克罗恩病的IB/IIA期研究。
Dis Colon Rectum. 2023 Oct 1;66(10):1359-1372. doi: 10.1097/DCR.0000000000002567. Epub 2023 Jan 4.
5
Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 months.体外扩增的异基因骨髓间充质干细胞治疗瘘管性克罗恩病的疗效在12个月时持久。
Surgery. 2024 Apr;175(4):984-990. doi: 10.1016/j.surg.2023.11.007. Epub 2023 Dec 13.
6
Direct Injection of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Crohn's Perianal Fistulizing Disease.直接注射体外扩增的同种异体骨髓间充质干细胞治疗小儿克罗恩病肛周瘘管病
Dis Colon Rectum. 2024 Feb 1;67(2):e115-e116. doi: 10.1097/DCR.0000000000002767. Epub 2023 Sep 19.
7
Remestemcel-L allogeneic bone marrow-derived mesenchymal stem cell product to treat medically refractory Crohn's colitis: preliminary phase IB/IIA study.用于治疗难治性克罗恩病结肠炎的Remestemcel-L同种异体骨髓间充质干细胞产品：IB/IIA期初步研究。
Br J Surg. 2022 Jul 15;109(8):653-655. doi: 10.1093/bjs/znac078.
8
A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.一项关于同种异体骨髓来源间充质干细胞体外扩增用于治疗儿童肛周瘘管型克罗恩病的 I 期研究。
Inflamm Bowel Dis. 2023 Dec 5;29(12):1912-1919. doi: 10.1093/ibd/izad100.
9
A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn's Disease.一项关于异体骨髓来源间充质基质细胞经体外扩增后用于治疗成人肛周瘘管型克罗恩病的 I/II 期临床试验。
Stem Cell Res Ther. 2024 May 14;15(1):140. doi: 10.1186/s13287-024-03746-9.
10
Adult allogenic bone marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulas in the setting of Crohn's disease.成人异体骨髓间充质干细胞用于治疗克罗恩病背景下的直肠阴道瘘。
Tech Coloproctol. 2022 Oct;26(10):831-832. doi: 10.1007/s10151-022-02667-0. Epub 2022 Aug 1.